Issuer Free Writing Prospectus
Filed Pursuant to Rule 433
Registration Statement No. 333-140034
FINAL PRICING TERMS
February 12, 2007
|
Issuer: |
|
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP). |
|
|
||
|
Securities Offered: |
|
Units consisting of one share of common stock and a warrant to purchase 0.25 shares of common stock, at an exercise price of $8.44 per share of common stock |
|
|
||
|
Maximum Number of Units |
|
4,249,668 |
|
|
||
|
Price Per Unit |
|
$8.47125 per Unit |
|
|
||
|
Estimated net Proceeds |
|
$33.5 Million |
The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively the issuer and the placement agent will arrange to send you the prospectus if you request it by calling 212-632-6717.